CPT® Code 80370

1. Indications

The CPT® Code 80370 is indicated for use in situations where there is a need to measure the levels of three or more skeletal muscle relaxants in a patient's biological samples. This testing is particularly relevant for patients who are being treated with these medications for various medical conditions. The following conditions may warrant the use of this laboratory test:

• Cerebral Palsy A neurological disorder that affects movement and muscle coordination, often requiring the use of muscle relaxants to manage spasticity.
• Multiple Sclerosis A chronic disease that affects the central nervous system, leading to muscle spasms and stiffness, which may be treated with skeletal muscle relaxants.
• Spinal Cord Injury Injuries to the spinal cord can result in muscle spasticity, necessitating the use of muscle relaxants for symptom management.
• Low Back Pain Chronic low back pain may be treated with muscle relaxants to alleviate muscle tension and discomfort.
• Neck Pain Similar to low back pain, neck pain can be associated with muscle spasms that may require pharmacological intervention.
• Fibromyalgia A condition characterized by widespread musculoskeletal pain, where muscle relaxants may be used to help relieve symptoms.
• Myofascial Pain Syndrome A chronic pain disorder that can involve muscle tightness and spasms, often treated with muscle relaxants.
• Tension Headaches These headaches can be associated with muscle tension in the neck and shoulders, and muscle relaxants may be prescribed to alleviate the associated discomfort.

2. Procedure

The procedure for testing skeletal muscle relaxants as indicated by CPT® Code 80370 involves several key steps to ensure accurate measurement of the substances in the patient's biological samples. The first step is the collection of a blood sample, which is obtained through a process known as venipuncture. This involves inserting a needle into a vein to draw blood, which is then collected in a sterile container for analysis. In addition to the blood sample, a urine sample is also required. This can be obtained either through random voiding, where the patient simply provides a sample during a normal urination, or through catheterization, which involves inserting a catheter into the bladder to collect urine directly. Once the samples are collected, they are subjected to various analytical techniques to quantify the specific skeletal muscle relaxants present. For instance, baclofen and cyclobenzaprine levels are measured using quantitative high-performance liquid chromatography coupled with tandem mass spectrometry, a highly sensitive and specific method for detecting and quantifying substances in biological samples. Serum and plasma samples are tested for dantrolene using spectrofluorometry, while carisoprodol is analyzed using quantitative gas chromatography-mass spectrometry. This comprehensive testing approach allows for the accurate identification and quantification of multiple skeletal muscle relaxants, facilitating effective patient management.

3. Post-Procedure

After the procedure, patients may be advised to follow specific post-collection care instructions, particularly regarding hydration and any potential side effects from the blood draw or catheterization. It is important for patients to remain well-hydrated to facilitate urine production for accurate testing results. Additionally, they should be monitored for any adverse reactions to the venipuncture, such as bruising or discomfort at the site. The results of the tests will typically be reviewed by the healthcare provider, who will interpret the findings in the context of the patient's overall treatment plan and medical history. Depending on the results, adjustments to medication regimens may be necessary to optimize therapeutic outcomes and minimize potential side effects associated with skeletal muscle relaxants.